Literature DB >> 9696793

The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Y Xiang1, D A Simpson, J Spiegel, A Zhou, R H Silverman, R C Condit.   

Abstract

Loss of vaccinia virus A18R gene function results in an aberrant transcription profile termed promiscuous transcription, defined as transcription within regions of the genome which are normally transcriptionally silent late during infection. Promiscuous transcription results in an increase in the intracellular concentration of double-stranded RNA, which in turn results in activation of the cellular 2-5A pathway and subsequent RNase L-catalyzed degradation of viral and cellular RNAs. One of three hypotheses could account for promiscuous transcription: (i) reactivation of early promoters late during infection, (ii) random transcription initiation, (iii) readthrough transcription from upstream promoters. Transcriptional analysis of several viral genes, presented here, argues strongly against the first two hypotheses. We have tested the readthrough hypothesis by conducting a detailed transcriptional analysis of a region of the vaccinia virus genome which contains three early genes (M1L, M2L, and K1L) positioned directly downstream of the intermediate gene, K2L. The results show that mutation of the A18R gene results in increased readthrough transcription of the M1L gene originating from the K2L intermediate promoter. A18R mutant infection of RNase L knockout mouse fibroblast (KO3) cells does not result in 2-5A pathway activation, yet the virus mutant is defective in late viral gene expression and remains temperature sensitive. These results demonstrate that the A18R gene product is a negative transcription elongation factor for postreplicative viral genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696793      PMCID: PMC109921     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

Authors:  G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  Mutation of vaccinia virus gene G2R causes suppression of gene A18R ts mutants: implications for control of transcription.

Authors:  R C Condit; Y Xiang; J I Lewis
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

3.  Purification of an RNA polymerase II transcript release factor from Drosophila.

Authors:  Z Xie; D H Price
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

4.  Phenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor.

Authors:  E P Black; R C Condit
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  A role for the H4 subunit of vaccinia RNA polymerase in transcription initiation at a viral early promoter.

Authors:  L Deng; S Shuman
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

6.  Vaccinia virus gene A18R encodes an essential DNA helicase.

Authors:  D A Simpson; R C Condit
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Vaccinia virus RNA helicase: an essential enzyme related to the DE-H family of RNA-dependent NTPases.

Authors:  S Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

8.  The vaccinia virus A18R gene product is a DNA-dependent ATPase.

Authors:  C D Bayliss; R C Condit
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

9.  Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Use of lysolecithin-permeabilized infected-cell extracts to investigate the in vitro biochemical phenotypes of poxvirus ts mutations altered in viral transcription activity.

Authors:  R C Condit; J I Lewis; M Quinn; L M Christen; E G Niles
Journal:  Virology       Date:  1996-04-01       Impact factor: 3.616

View more
  23 in total

1.  Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins.

Authors:  Jeffrey O Langland; John C Kash; Victoria Carter; Matthew J Thomas; Michael G Katze; Bertram L Jacobs
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

3.  Diversity in the acute CD8 T cell response to vaccinia virus in humans.

Authors:  Lichen Jing; Tiana M Chong; Christopher L McClurkan; Jay Huang; Brian T Story; David M Koelle
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

4.  Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells.

Authors:  Roderick Gedey; Xiao-Lu Jin; Olivia Hinthong; Joanna L Shisler
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Ectromelia virus accumulates less double-stranded RNA compared to vaccinia virus in BS-C-1 cells.

Authors:  Tiffany R Frey; Michael H Lehmann; Colton M Ryan; Marie C Pizzorno; Gerd Sutter; Adam R Hersperger
Journal:  Virology       Date:  2017-09       Impact factor: 3.616

6.  Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.

Authors:  Z Chen; Y Li; R M Krug
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

7.  A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription.

Authors:  Steven G Cresawn; Richard C Condit
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

8.  Vaccinia Virus Encodes a Novel Inhibitor of Apoptosis That Associates with the Apoptosome.

Authors:  Melissa R Ryerson; Monique M Richards; Marc Kvansakul; Christine J Hawkins; Joanna L Shisler
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

9.  Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus.

Authors:  William D Arndt; Stacy D White; Brian P Johnson; Trung Huynh; Jeffrey Liao; Heather Harrington; Samantha Cotsmire; Karen V Kibler; Jeffrey Langland; Bertram L Jacobs
Journal:  Virology       Date:  2016-07-26       Impact factor: 3.616

10.  Nucleoside Triphosphate Phosphohydrolase I (NPH I) Functions as a 5' to 3' Translocase in Transcription Termination of Vaccinia Early Genes.

Authors:  Ryan Hindman; Paul Gollnick
Journal:  J Biol Chem       Date:  2016-05-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.